Literature DB >> 16052360

Kinetics of Cryptosporidium parvum-specific cytokine responses in healing and nonhealing murine models of C. parvum infection.

Inderpal Singh1, Cynthia Theodos, Wenjun Li, Saul Tzipori.   

Abstract

Susceptibility or resistance to infection with Cryptosporidium parvum correlates with the ability of mice to produce characteristic panels of cytokines in response to infection. Both adult healing and nonhealing mouse models of cryptosporidiosis were used to study the cell-mediated immune response during the course of C. parvum infection. Mesenteric lymph node (MLN) lymphocytes from both mouse models were proliferated after ex vivo re-stimulation with C. parvum sporozoite antigen. Study of the cytokine profile from the supernatant of proliferated MLN cells revealed that healing mice produced greater levels of Th1 (IFN-gamma and IL-2) and moderate amounts of Th2 (IL-4, IL-5, IL-6, and IL-10) cytokines throughout the course of infection. Whereas, MLN cells from nonhealing mice produced no IFN-gamma, low levels of IL-2 and IL-4, and higher levels of IL-5, IL-6, and IL-10 cytokines. These results suggest that the capacity to produce both Th1 and Th2 cytokines, rather than the presence of Th2 cytokines alone, determines the effective immune response against C. parvum infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052360     DOI: 10.1007/s00436-005-1436-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  35 in total

1.  Experimental cryptosporidiosis in laboratory mice.

Authors:  D Sherwood; K W Angus; D R Snodgrass; S Tzipori
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

2.  Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice.

Authors:  A R Hayward; K Chmura; M Cosyns
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

3.  The role of humoral immunity in Cryptosporidium spp. infection. Studies with B cell-depleted mice.

Authors:  R Taghi-Kilani; L Sekla; K T Hayglass
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

4.  Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice.

Authors:  M Cosyns; S Tsirkin; M Jones; R Flavell; H Kikutani; A R Hayward
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.

Authors:  S Lacroix; R Mancassola; M Naciri; F Laurent
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction.

Authors:  I-Sarah Lean; Stuart A C McDonald; Mona Bajaj-Elliott; Richard C G Pollok; Michael J G Farthing; Vincent McDonald
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

7.  Persistent Cryptosporidium infection in congenitally athymic (nude) mice.

Authors:  J Heine; H W Moon; D B Woodmansee
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Cryptosporidium infections in inbred strains of mice.

Authors:  F J Enriquez; C R Sterling
Journal:  J Protozool       Date:  1991 Nov-Dec

9.  Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice.

Authors:  L E Perryman; P H Mason; C E Chrisp
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  In vitro proliferation and production of gamma interferon by murine CD4+ cells in response to Cryptosporidium parvum antigen.

Authors:  J A Harp; W M Whitmire; R Sacco
Journal:  J Parasitol       Date:  1994-02       Impact factor: 1.276

View more
  3 in total

1.  Cryptosporidiosis in rhesus macaques challenged during acute and chronic phases of SIV infection.

Authors:  Inderpal Singh; Angela Carville; Saul Tzipori
Journal:  AIDS Res Hum Retroviruses       Date:  2011-03-27       Impact factor: 2.205

2.  Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice.

Authors:  Rihua Xu; Honglin Jia; Mohamad Alaa Terkawi; Xuenan Xuan; Heping Zhang
Journal:  Curr Microbiol       Date:  2011-02-20       Impact factor: 2.188

3.  Cryptosporidium parvum, a potential cause of colic adenocarcinoma.

Authors:  Gabriela Certad; Tramy Ngouanesavanh; Karine Guyot; Nausicaa Gantois; Thierry Chassat; Anthony Mouray; Laurence Fleurisse; Anthony Pinon; Jean-Charles Cailliez; Eduardo Dei-Cas; Colette Creusy
Journal:  Infect Agent Cancer       Date:  2007-11-21       Impact factor: 2.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.